Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: A double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

J. Nam, E. Villeneuve, E.M.A. Hensor, P.G. Conaghan, Helen Keen, M.H. Buch, A.K.S. Gough, M.J. Green, P.S. Helliwell, A.M. Keenan, A.W. Morgan, M.A. Quinn, R.J. Reece, D.M.F.M. Van Der Heijde, R.J. Wakefield, P.D. Emery

    Research output: Contribution to journalArticlepeer-review

    113 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: A double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Neuroscience

    Immunology and Microbiology

    Agricultural and Biological Sciences